Report overview
Gene therapy is?a medical approach that treats or prevents disease by correcting the underlying genetic problem. Gene therapy techniques allow doctors to treat a disorder by altering a person's genetic makeup instead of using drugs or surgery.
This report aims to provide a comprehensive presentation of the global market for Human Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Gene Therapy. This report contains market size and forecasts of Human Gene Therapy in global, including the following market information:
Global Human Gene Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Human Gene Therapy Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Human Gene Therapy companies in 2022 (%)
The global Human Gene Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Non-viral Vectors Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Gene Therapy include Biogen, Sarepta Therapeutics, Gilead Sciences, Amgen, Novartis, Orchard Therapeutics, Spark Therapeutics, Agc Biologics and Anges, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Gene Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Gene Therapy Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Gene Therapy Market Segment Percentages, by Type, 2022 (%)
Non-viral Vectors
Viral Vectors
Global Human Gene Therapy Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Gene Therapy Market Segment Percentages, by Application, 2022 (%)
Neurological Diseases
Cancer
DMD (Duchenne Muscular Dystrophy)
Hepatological Diseases
Others
Global Human Gene Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Gene Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Gene Therapy revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Gene Therapy revenues share in global market, 2022 (%)
Key companies Human Gene Therapy sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Human Gene Therapy sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen
Sarepta Therapeutics
Gilead Sciences
Amgen
Novartis
Orchard Therapeutics
Spark Therapeutics
Agc Biologics
Anges
Bluebird Bio
Jazz Pharmaceuticals
Dynavax Technologies
Human Stem Cells Institute
Sibiono Genetech
Shanghai Sunway Biotech
Uniqure N.V.
Gensight Biologics S.A.
Celgene Corporation
Cellectis
Sangamo Therapeutics
Mustang Bio
AGTC
Poseida Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Gene Therapy, market overview.
Chapter 2: Global Human Gene Therapy market size in revenue and volume.
Chapter 3: Detailed analysis of Human Gene Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Gene Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Gene Therapy capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
